Literature DB >> 7818284

sICAM-1, sIL-2R and beta 2-microglobulin serum levels in patients affected with psoriasis: relationship with disease severity.

M Carducci, A Mussi, C Bonifati, M Fazio, F Ameglio.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7818284     DOI: 10.1007/bf00371804

Source DB:  PubMed          Journal:  Arch Dermatol Res        ISSN: 0340-3696            Impact factor:   3.017


× No keyword cloud information.
  5 in total

Review 1.  [Beta 2-microglobulin: structure, function, metabolism and changes in diseases].

Authors:  C Vincent
Journal:  Ann Dermatol Venereol       Date:  1990       Impact factor: 0.777

2.  Elevated serum-soluble ELAM-1 levels in patients with severe plaque-type psoriasis.

Authors:  L Kowalzick; K Neuber; M Weichenthal; I Köhler; J Ring
Journal:  Arch Dermatol Res       Date:  1994       Impact factor: 3.017

3.  Clinical improvement in psoriasis during dithranol/UVB therapy does not correspond with a decrease in elevated serum soluble ICAM-1 levels.

Authors:  L Kowalzick; H Bildau; K Neuber; I Köhler; J Ring
Journal:  Arch Dermatol Res       Date:  1993       Impact factor: 3.017

4.  Elevated levels of interleukin 2 receptor in sera of patients with atopic dermatitis and psoriasis.

Authors:  A Kapp; A Piskorski; E Schöpf
Journal:  Br J Dermatol       Date:  1988-12       Impact factor: 9.302

5.  Soluble intercellular adhesion molecule-1 levels in patients with psoriasis.

Authors:  R E Schopf; S Naumann; M Rehder; B Morsches
Journal:  Br J Dermatol       Date:  1993-01       Impact factor: 9.302

  5 in total
  1 in total

1.  Interleukin 6 and 8 levels in plasma and fibroblast cultures in psoriasis.

Authors:  Anna Zalewska; Ewa Głowacka; Janina Wyczółkowska; Henryk Tchórzewski; Joanna Narbutt; Anna Sysa-Jedrzejowska
Journal:  Mediators Inflamm       Date:  2006       Impact factor: 4.711

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.